Akebia Therapeutics Inc. (AKBA)
1.90
-0.02 (-1.04%)
At close: Apr 01, 2025, 3:59 PM
1.93
1.37%
Pre-market: Apr 02, 2025, 04:04 AM EDT
Akebia Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -69.41M | -51.92M | -92.56M | -282.84M | -383.46M | -279.66M | -143.59M | -76.91M | -135.75M | -60.72M | -37.03M | -13.17M | -8.2M |
| Depreciation & Amortization | 37.5M | 41.85M | 37.7M | 37.97M | 33.59M | 38.65M | 2.42M | 617K | 296K | 96K | 49K | 1.28K | n/a |
| Stock-Based Compensation | 7.78M | 9.32M | 17.85M | 22.73M | 24.46M | 11.93M | 19.04M | 8.87M | 5.83M | 4.71M | 6.01M | 1.56M | 122K |
| Other Working Capital | -13.96M | -13.94M | -34.42M | -46.81M | -35.52M | -49.1M | -11.11M | -14.11M | 187.01M | 2.71M | -151K | 1.98M | -804K |
| Other Non-Cash Items | -16.53M | -1.9M | -34.7M | 41.01M | 24.61M | 77.35M | 16.95M | 4.02M | 800K | 558K | 268K | 760.42K | 1.67M |
| Deferred Income Tax | n/a | n/a | n/a | 36.58M | 204.08M | -6.63M | -28.34M | n/a | n/a | n/a | n/a | -2.42M | n/a |
| Change in Working Capital | n/a | -20.73M | -1.44M | -108.42M | -13.67M | -99.07M | 36.02M | 7.25M | 186.73M | 2.94M | 3.22M | 1.93M | -808K |
| Operating Cash Flow | -40.66M | -23.38M | -73.15M | -252.97M | -110.39M | -257.44M | -97.49M | -56.16M | 57.91M | -52.41M | -27.48M | -11.33M | -7.21M |
| Capital Expenditures | -33K | n/a | -114K | -59K | -317K | -6.66M | -1.61M | -1.62M | -2.66M | -414K | -229K | -19.73K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | 39.69M | n/a | 6.15M | 1.62M | 2.66M | 414K | 229K | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | -99.93M | n/a | -224.22M | -330.64M | -147.01M | -77.17M | -77.71M | -13.39M | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | 40M | 60.24M | 217.83M | 256.27M | 155M | 162.38M | 63.9M | 12.59M | 1.99M | 1.37M |
| Other Investing Acitivies | n/a | n/a | n/a | 40M | -39.69M | 217.83M | 32.05M | -1.62M | -2.66M | -414K | -229K | -11.41M | 1.37M |
| Investing Cash Flow | -33K | n/a | -114K | 39.94M | -40M | 211.18M | 36.59M | -177.26M | 12.71M | -13.69M | -65.35M | -11.42M | 1.37M |
| Debt Repayment | 7.9M | -32M | -33M | n/a | 19.98M | 62.67M | -19K | -5K | -20K | -7K | 234K | n/a | n/a |
| Common Stock Repurchased | -1.27M | n/a | n/a | n/a | n/a | -426K | n/a | n/a | n/a | n/a | -162K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 385K | 1K | 40.07M | 133.73M | 1.23M | 560K | 647K | 1.31M | 124K | 130K | n/a | 42.33M | n/a |
| Financial Cash Flow | 49.66M | -25.21M | 14.6M | 133.73M | 231.72M | 88.97M | 96.56M | 116.24M | 66.95M | 83.09M | 104.4M | 42.33M | 2.48M |
| Net Cash Flow | 8.97M | -48.59M | -58.67M | -79.29M | 81.33M | 42.7M | 35.66M | -117.18M | 137.56M | 17M | 11.56M | 19.57M | -3.37M |
| Free Cash Flow | -40.69M | -23.38M | -73.27M | -253.02M | -110.7M | -264.1M | -99.1M | -57.78M | 55.24M | -52.82M | -27.71M | -11.35M | -7.21M |